ABPI responds to PM’s Brexit comments
The ABPI has responded to the Prime Minister’s comments on the possibility of a ‘no deal’ Brexit. The Prime … read more »
ABPI Clinical Trials Report for 2020 sets out strategy to restart non-Covid research
According to data published by the Association of the British Pharmaceutical Industry (ABPI) in its second annual report on the … read more »
NHS Reset Campaign sets out to reform health and care in post-COVID-19 future
The NHS Confederation has released its report, NHS Reset: a new direction for health and care, as part of the … read more »
UK and EU pharmaceutical industry jointly urges protection of medicines before Brexit transition period ends
As the deadline for Brexit negotiations approaches, the UK and EU pharmaceutical industry trade bodies, the Association of the British … read more »
ABPI responds to National Genomic Healthcare Strategy
The Department of Health and Social Care recently published its National Genomic Healthcare Strategy, which the Association of the British … read more »
ABPI responds to UK-Japan trade agreement
The Association of the British Pharmaceutical Industry (ABPI) has commented on the new deal between the UK and Japan, as … read more »
ABPI responds to inquiry report on COVID-19 and international trade
The Association of the British Pharmaceutical Industry (ABPI) has given a mixed welcome to the report of the International Trade … read more »
ABPI praises pharma’s UK R&D investments
The Association of the British Pharmaceutical Industry (ABPI) has lauded the industry’s contributions to UK research and development (R&D), releasing … read more »
Life Sciences Recovery Roadmap launched by industry groups
Bodies representing the life sciences industry have united to create the Life Sciences Recovery Roadmap, a report designed to guide … read more »
ABPI launches Code consultation
The Association of the British Pharmaceutical Industry (ABPI) has launched its consultation to refresh the Code of Practice for the … read more »
